Astellas Pharma
Pharmaceutical ManufacturingTokio, Japan10001+ Employees
Astellas Pharma is a global pharmaceutical manufacturing company based in Tokyo, Japan, with more than 10,000 employees. The company focuses on developing transformative therapies in oncology, ophthalmology, urology, immunology, and women's health, supported by its research and development programs to address diseases with high unmet medical need. It pursues life sciences innovations and patient-centered healthcare solutions, and its website is https://astellas.com. In 2026, Astellas expanded its offices to China and invested in facilities in Dublin, Ireland, reflecting an increased international footprint. That year also saw a leadership transition with Takahiko Iwaya named chief strategy officer effective July 1, 2026, following the departure of the prior CSO.